Nature publishes new research on genetic causes of colorectal cancer
In the UK study, researchers analysed 2,023 bowel cancers from the 100,000 Genomes Project
Read Moreby PharmaTimes | Aug 19, 2024 | News | 0
In the UK study, researchers analysed 2,023 bowel cancers from the 100,000 Genomes Project
Read Moreby Jen Brogan | Aug 15, 2024 | News | 0
Combined, Crohn’s disease and ulcerative colitis affect over 500,000 people in the UK
Read Moreby Jen Brogan | Jul 31, 2024 | News | 0
The latest collaboration marks Apollo’s sixth agreement with a research institution
Read Moreby Jen Brogan | Jul 19, 2024 | News | 0
Chronic pelvic pain is a disabling condition that affects around one in four women worldwide
Read Moreby Jen Brogan | Jun 28, 2024 | News | 0
The study found an increase in incidence among young people and people from deprived areas
Read Moreby Jen Brogan | Jun 27, 2024 | News | 0
Lennox-Gastaut syndrome affects up to 5% of children living with paediatric epilepsy
Read Moreby Jen Brogan | Jun 19, 2024 | News | 0
The serious condition is responsible for approximately 11 million deaths worldwide every year
Read Moreby Jen Brogan | May 29, 2024 | News | 0
Affecting more than 7 million people in the UK, cardiovascular diseases are conditions that affect the heart or circulation
Read Moreby Jen Brogan | Apr 24, 2024 | News | 0
According to the World Health Organization, CVDs are responsible for an estimated 17.9 million deaths every year
Read Moreby Jen Brogan | Apr 11, 2024 | News | 0
Prostate cancer is responsible for around 12,000 deaths a year in the UK and is the second biggest cause of death for men
Read Moreby Jen Brogan | Mar 4, 2024 | News | 0
In the UK alone, the aggressive form of cancer affects around 52,000 men every year
Read Moreby Jen Brogan | Jan 10, 2024 | News | 0
The partnership will advance VTP-500 from early development to phase 2 clinical trials
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
